Origins of FL genes

Tier 1 FL genes

Gene Status First FL study Other lists
ACTB FL Tier 1 Dreval et al DLBCL, PMBL, MZL
ARID1A FL Tier 1 Krysiak et al BL, DLBCL, PMBL, MZL
ATP6AP1 FL Tier 1 Green et al
ATP6V1B2 FL Tier 1 Green et al
B2M FL Tier 1 Morin et al BL, DLBCL, PMBL, MCL
BCL10 FL Tier 1 Russler-germain et al DLBCL, MZL
BCL2 FL Tier 1 Morin et al BL, DLBCL, PMBL
BCL6 FL Tier 1 Dreval et al BL, DLBCL
BCL7A FL Tier 1 Krysiak et al BL, DLBCL, PMBL, MZL
BTK FL Tier 1 Krysiak et al DLBCL
CARD11 FL Tier 1 Morin et al BL, DLBCL, MCL, MZL
CCND3 FL Tier 1 Morin et al BL, DLBCL, PMBL, MZL
CD83 FL Tier 1 Russler-germain et al BL, DLBCL, PMBL
CREBBP FL Tier 1 Pasqualucci et al BL, DLBCL, PMBL, MZL
CTSS FL Tier 1 Bararia et al
EBF1 FL Tier 1 Dreval et al BL, DLBCL, PMBL
EEF1A1 FL Tier 1 Green et al DLBCL, PMBL
EP300 FL Tier 1 Pasqualucci et al DLBCL, MZL
EZH2 FL Tier 1 Morin et al BL, DLBCL, PMBL, MZL
FAS FL Tier 1 Morin et al DLBCL, PMBL, MZL
FOXO1 FL Tier 1 Morin et al BL, DLBCL, PMBL, MZL
GNA13 FL Tier 1 Morin et al BL, DLBCL, PMBL
GNAI2 FL Tier 1 Dreval et al BL, DLBCL
HIST1H1B FL Tier 1 Krysiak et al BL, DLBCL, PMBL
HIST1H1C FL Tier 1 Morin et al BL, DLBCL, PMBL
HIST1H1D FL Tier 1 Krysiak et al DLBCL, PMBL, MZL
HIST1H1E FL Tier 1 Krysiak et al BL, DLBCL, PMBL
HIST1H2AC FL Tier 1 Krysiak et al DLBCL
HIST1H2AG FL Tier 1 Krysiak et al BL, DLBCL, MZL
HIST1H2AM FL Tier 1 Krysiak et al BL, DLBCL
HIST1H2BC FL Tier 1 Krysiak et al DLBCL, PMBL
HIST1H2BG FL Tier 1 Krysiak et al
HVCN1 FL Tier 1 Krysiak et al DLBCL
IGLL5 FL Tier 1 Russler-germain et al BL, DLBCL, PMBL
IRF8 FL Tier 1 Morin et al BL, DLBCL, PMBL
KLHL6 FL Tier 1 Morin et al DLBCL, MZL
KMT2D FL Tier 1 Morin et al BL, DLBCL, PMBL, MCL, MZL
MAP2K1 FL Tier 1 Louissaint et al DLBCL
MEF2B FL Tier 1 Morin et al DLBCL, MCL
MYC FL Tier 1 Rossi et al BL, DLBCL, PMBL, MZL
PIM1 FL Tier 1 Dreval et al BL, DLBCL, PMBL
POU2AF1 FL Tier 1 Krysiak et al DLBCL, MZL
POU2F2 FL Tier 1 Krysiak et al DLBCL
RRAGC FL Tier 1 Okosun et al DLBCL
SGK1 FL Tier 1 Morin et al DLBCL, PMBL
SMARCA4 FL Tier 1 Green et al BL, DLBCL, PMBL, MCL
SOCS1 FL Tier 1 Dreval et al DLBCL, PMBL, MZL
STAT6 FL Tier 1 Yildiz et al DLBCL, PMBL, MZL
TBL1XR1 FL Tier 1 Dreval et al BL, DLBCL, PMBL, MZL
TMSB4X FL Tier 1 Dreval et al DLBCL, PMBL
TNFAIP3 FL Tier 1 Dreval et al DLBCL, PMBL, MZL
TNFRSF14 FL Tier 1 Cheung et al BL, DLBCL, MZL
TP53 FL Tier 1 Morin et al BL, DLBCL, PMBL, MCL, MZL
VMA21 FL Tier 1 Hubschmann et al

Tier 2 FL genes

Gene Status First FL study Other lists
ABL2 FL Tier 2 Russler-germain et al
ACTG1 FL Tier 2 Hubschmann et al DLBCL, PMBL, MZL
ATP6V1A FL Tier 2 Hubschmann et al
BTG1 FL Tier 2 Dreval et al BL, DLBCL, PMBL, MZL
BTG2 FL Tier 2 Dreval et al BL, DLBCL
CD70 FL Tier 2 Russler-germain et al DLBCL
CD79B FL Tier 2 Dreval et al BL, DLBCL
CDC42BPB FL Tier 2 Hubschmann et al MZL
CILP FL Tier 2 Russler-germain et al
CPNE8 FL Tier 2 Hubschmann et al
CXCR4 FL Tier 2 Krysiak et al BL, DLBCL, MZL
CYP2A6 FL Tier 2 Russler-germain et al
DDX3X FL Tier 2 Dreval et al BL, DLBCL, PMBL
DHX15 FL Tier 2 Hubschmann et al
DUSP2 FL Tier 2 Dreval et al DLBCL, PMBL
EGR1 FL Tier 2 Krysiak et al PMBL, MZL
FZR1 FL Tier 2 Hubschmann et al
GBP7 FL Tier 2 Russler-germain et al
GRM6 FL Tier 2 Russler-germain et al
HIST1H2BD FL Tier 2 Krysiak et al
HIST1H2BM FL Tier 2 Krysiak et al
HIST1H3G FL Tier 2 Krysiak et al
HIST1H3I FL Tier 2 Krysiak et al BL
IRF4 FL Tier 2 Dreval et al DLBCL, PMBL
ITPKB FL Tier 2 Dreval et al DLBCL, PMBL
JUP FL Tier 2 Hubschmann et al
KIR3DL1 FL Tier 2 Russler-germain et al
KLF2 FL Tier 2 Dreval et al DLBCL, PMBL, MZL
LAPTM5 FL Tier 2 Hubschmann et al DLBCL
LTB FL Tier 2 Dreval et al DLBCL, PMBL
MAGEC1 FL Tier 2 Russler-germain et al
MAP7D1 FL Tier 2 Russler-germain et al
MEF2C FL Tier 2 Laurent et al DLBCL
MGEA5 FL Tier 2 Hubschmann et al
MKI67 FL Tier 2 Russler-germain et al BL
MYCBP2 FL Tier 2 Hubschmann et al
MYD88 FL Tier 2 Dreval et al DLBCL, MZL
NEB FL Tier 2 Ma et al
NFKBIA FL Tier 2 Russler-germain et al DLBCL, PMBL
OR8H2 FL Tier 2 Russler-germain et al
P2RY8 FL Tier 2 Dreval et al BL, DLBCL, PMBL
PDS5B FL Tier 2 Hubschmann et al DLBCL
PPP4C FL Tier 2 Hubschmann et al
PRKDC FL Tier 2 Hubschmann et al DLBCL, PMBL
PTPRD FL Tier 2 Dreval et al DLBCL, PMBL, MZL
PZP FL Tier 2 Russler-germain et al
RBM6 FL Tier 2 Hubschmann et al
RHOA FL Tier 2 Ma et al BL, DLBCL, PMBL
S1PR2 FL Tier 2 Dreval et al BL, DLBCL, PMBL
SHROOM3 FL Tier 2 Russler-germain et al
SRRM2 FL Tier 2 Russler-germain et al DLBCL
STAB2 FL Tier 2 Russler-germain et al
TBC1D3F FL Tier 2 Ma et al
TMEM30A FL Tier 2 Morin et al DLBCL
TPP1 FL Tier 2 Hubschmann et al
TPTE FL Tier 2 Ma et al
XIRP2 FL Tier 2 Russler-germain et al
ZNF608 FL Tier 2 Krysiak et al DLBCL

Tier 3 FL genes

Gene Status First FL study Other lists

References

1.
Rossi D, Berra E, Cerri M, Deambrogi C, Barbieri C, Franceschetti S, Lunghi M, Conconi A, Paulli M, Matolcsy A, Pasqualucci L, Capello D, Gaidano G. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. Haematologica. 2006 Oct;91(10):1405–1409. PMID: 17018394
2.
Ma MCJ, Tadros S, Bouska A, Heavican T, Yang H, Deng Q, Moore D, Akhter A, Hartert K, Jain N, Showell J, Ghosh S, Street L, Davidson M, Carey C, Tobin J, Perumal D, Vose JM, Lunning MA, Sohani AR, Chen BJ, Buckley S, Nastoupil LJ, Davis RE, Westin JR, Fowler NH, Parekh S, Gandhi M, Neelapu S, Stewart D, Bhalla K, Iqbal J, Greiner T, Rodig SJ, Mansoor A, Green MR. Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma. Haematologica. 2022 Mar;107(3):690–701. PMCID: PMC8883549
3.
Laurent C, Trisal P, Tesson B, Seth S, Beyou A, Roulland S, Lesne B, Van Acker N, Cerapio JP, Chartier L, Guille A, Stokes M, Huang C, Huet S, Gandhi A, Morschauser F, Xerri L. Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significance. Blood. 2024 Oct;
4.
Bararia D, Hildebrand JA, Stolz S, Haebe S, Alig S, Trevisani CP, Osorio-Barrios F, Bartoschek MD, Mentz M, Pastore A, Gaitzsch E, Heide M, Jurinovic V, Rautter K, Gunawardana J, Sabdia MB, Szczepanowski M, Richter J, Klapper W, Louissaint A, Ludwig C, Bultmann S, Leonhardt H, Eustermann S, Hopfner KP, Hiddemann W, von Bergwelt-Baildon M, Steidl C, Kridel R, Tobin JWD, Gandhi MK, Weinstock DM, Schmidt-Supprian M, Sárosi MB, Rudelius M, Passerini V, Mautner J, Weigert O. Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma. Cell Rep. 2020 May 5;31(5):107522.
5.
Cheung KJJ, Johnson NA, Affleck JG, Severson T, Steidl C, Ben-Neriah S, Schein J, Morin RD, Moore R, Shah SP, Qian H, Paul JE, Telenius A, Relander T, Lam W, Savage K, Connors JM, Brown C, Marra MA, Gascoyne RD, Horsman DE. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res. 2010 Nov 15;70(22):9166–9174.
6.
Dreval K, Hilton LK, Cruz M, Shaalan H, Ben-Neriah S, Boyle M, Collinge B, Coyle KM, Duns G, Farinha P, Grande BM, Meissner B, Pararajalingam P, Rushton CK, Slack GW, Wong J, Mungall AJ, Marra MA, Connors JM, Steidl C, Scott DW, Morin RD. Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns. Blood. 2023 Aug 10;142(6):561–573. PMCID: PMC10644066
7.
Hübschmann D, Kleinheinz K, Wagener R, Bernhart SH, López C, Toprak UH, Sungalee S, Ishaque N, Kretzmer H, Kreuz M, Waszak SM, Paramasivam N, Ammerpohl O, Aukema SM, Beekman R, Bergmann AK, Bieg M, Binder H, Borkhardt A, Borst C, Brors B, Bruns P, Carrillo de Santa Pau E, Claviez A, Doose G, Haake A, Karsch D, Haas S, Hansmann ML, Hoell JI, Hovestadt V, Huang B, Hummel M, Jäger-Schmidt C, Kerssemakers JNA, Korbel JO, Kube D, Lawerenz C, Lenze D, Martens JHA, Ott G, Radlwimmer B, Reisinger E, Richter J, Rico D, Rosenstiel P, Rosenwald A, Schillhabel M, Stilgenbauer S, Stadler PF, Martín-Subero JI, Szczepanowski M, Warsow G, Weniger MA, Zapatka M, Valencia A, Stunnenberg HG, Lichter P, Möller P, Loeffler M, Eils R, Klapper W, Hoffmann S, Trümper L, ICGC MMML-Seq consortium, ICGC DE-Mining consortium, BLUEPRINT consortium, Küppers R, Schlesner M, Siebert R. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas. Leukemia. 2021 Jul;35(7):2002–2016. PMCID: PMC8257491
8.
Krysiak K, Gomez F, White BS, Matlock M, Miller CA, Trani L, Fronick CC, Fulton RS, Kreisel F, Cashen AF, Carson KR, Berrien-Elliott MM, Bartlett NL, Griffith M, Griffith OL, Fehniger TA. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood. 2017 Jan 26;129(4):473–483. PMCID: PMC5270390
9.
Louissaint A, Schafernak KT, Geyer JT, Kovach AE, Ghandi M, Gratzinger D, Roth CG, Paxton CN, Kim S, Namgyal C, Morin R, Morgan EA, Neuberg DS, South ST, Harris MH, Hasserjian RP, Hochberg EP, Garraway LA, Harris NL, Weinstock DM. Pediatric-type nodal follicular lymphoma: A biologically distinct lymphoma with frequent MAPK pathway mutations. Blood. 2016 Aug 25;128(8):1093–1100. PMCID: PMC5000844
10.
Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJM, Connors JM, Hirst M, Gascoyne RD, Marra MA. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011 Jul 27;476(7360):298–303. PMCID: PMC3210554
11.
Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, Paul JE, Boyle M, Woolcock BW, Kuchenbauer F, Yap D, Humphries RK, Griffith OL, Shah S, Zhu H, Kimbara M, Shashkin P, Charlot JF, Tcherpakov M, Corbett R, Tam A, Varhol R, Smailus D, Moksa M, Zhao Y, Delaney A, Qian H, Birol I, Schein J, Moore R, Holt R, Horsman DE, Connors JM, Jones S, Aparicio S, Hirst M, Gascoyne RD, Marra MA. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet. 2010 Feb;42(2):181–185. PMCID: PMC2850970
12.
Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Al Seraihi AF, Richter J, Bernhart SH, Efeyan A, Iqbal S, Matthews J, Clear A, Guerra-Assunção JA, Bödör C, Quentmeier H, Mansbridge C, Johnson P, Davies A, Strefford JC, Packham G, Barrans S, Jack A, Du MQ, Calaminici M, Lister TA, Auer R, Montoto S, Gribben JG, Siebert R, Chelala C, Zoncu R, Sabatini DM, Fitzgibbon J. Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma. Nat Genet. 2016 Feb;48(2):183–188. PMCID: PMC4731318
13.
Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, Rossi D, Chadburn A, Murty VV, Mullighan CG, Gaidano G, Rabadan R, Brindle PK, Dalla-Favera R. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature. 2011 Mar 10;471(7337):189–195. PMCID: PMC3271441
14.
Russler-Germain DA, Krysiak K, Ramirez CA, Mosior M, Watkins MP, Gomez F, Skidmore ZL, Trani L, Gao F, Geyer S, Cashen A, Mehta-Shah N, Kahl B, Bartlett N, Alderuccio J, Lossos I, Ondrejka S, Hsi E, Martin P, Leonard J, Griffith M, Griffith O, Fehniger T. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303. Blood Advances. 2023;7:5524–5539.
15.
Yildiz M, Li H, Bernard D, Amin NA, Ouillette P, Jones S, Saiya-Cork K, Parkin B, Jacobi K, Shedden K, Wang S, Chang AE, Kaminski MS, Malek SN. Activating STAT6 mutations in follicular lymphoma. Blood. 2015 Jan 22;125(4):668–679. PMCID: PMC4729538